Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 230-039-0 | CAS number: 6921-34-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Additional information
At the present time, no data about repeated dose toxicity endpoint are available for the substance as described in section 1.2. For this reason, some scientific evidence of toxicity under repeated administration of tetrahydrofuran (stabilizaer additive of benzylmagnesium chloride) were assessed.
In the NTP 1998 study, 10 male and 10 female rats have been exposed to 0, 66, 200, 600, 1800, 5000 tetrahydrofuran inhalation for 14 weeks, 5 days per week. Immediately after exposure, rats in the 5000 ppm group exhibited ataxia, with irregular movements and lack of coordination. Hematology and clinical chemistry data differences between exposure groups did not demonstrate a strong exposure relationship and only occurred in the 5000 ppm group. However, these data were not toxicologically relevant. The decrease of thymus and spleen weights were not associated with readly appreciable histopathological changes and may have been due to stress associated with tetrahydrofuran administration.
Furthermore, 10 male and 10 female mice have been exposed to 0 (chamber controls), 66, 200, 600, 1800, 5000 tetrahydrofuran inhalation for 14 weeks, 5 days per week. Two male mice exposed to 5000 ppm died during week 2 and 8 of the study; one male mouse of the same exposure level was killed in a moribund state during week 4. All female mice survived until the end of the study. The final mean body weights and body weight gains of all exposed group of male mice were similar to those of the chamber controls. The final mean body weights and body weight gains of female mice exposed to 5000 ppm were significantly greater than those of the chamber controls. Mice exposed to 1800 or 5000 ppm were observed in a state of narcosis during exposure period. Mice exposed to 1800 ppm recovered immediately after exposure, while 5000 ppm exposed mice required up to 2 hours for recovery. Absolute and relative liver weights of male mice exposed to 600 ppm or greater and of female mice exposed to 1800 or 5000 ppm were significantly greater than those of the chamber controls. Absolute and relative lung and heart weights of female mice exposed to 5000 ppm were significantly less than those of the chamber controls. Absolute and relative thymus weights of male mice exposed to 600, 1800 or 5000 ppm were significantlly less than those of the chamber controls. Absolute and relative spleen weights of male and female mice exposed to 5000 ppm were significantly less tha those of the chamber controls. Although there were decrease in thymus and spleen weights, corresponding histopatologic changes were not readly appreciable. However, the spleens of male and female mice exposed to 5000 ppm had smaller cross sections. The significance of these organ weight differences is not clear, but the differences may be due to stress associated with tetrahydrofuran exposure. No exposure-related gross lesions were observed in male and female mice at necropsy.The adrenal glands of all female mice exposed to 5000 ppm had mild degeneration of the X-zone of the innermost cortex. Furthermore, uterine atrophy, characterized grossly by small by small uteri and microscopically by fewer numbers of uterine glands, was observed in all female mice of the 5000 ppm group. However, it is not known whether adrenal gland X-zone degeneration or utherine atrophy represented an acceleration of normal aging changes due to a hormonal effect or an organ-specific, exposure-related, target-organ effect.
In an additional study groups of male and female rats Crl:CD BR received tetrahydrofuran inhalation exposure at concentrations of 0, 500, 1500 and 5000 ppm.
This study indicates that the principal neurobehavioral effect of exposure to 1500 ppm and greater concentrations of THF is acute behavioral sedation which dissipates rapidly upon termination of exposure. These results are consistent with reports of occupational over exposure in which transient effects on the central nervous system were noted. There was no evidence that subchronic exposure caused enduring adverse effects on nervous system structure or function. For neurobehavioral end points, the no-observed-effect level for THF in subchronic exposure scenarios was 500 ppm, based on concentration-dependent findings of acute and transient behavioral sedation with single or repeated exposure to 1500 or 5000 ppm.
Justification for classification or non-classification
At the present time, no data about repeated dose toxicity endpoint are available for the substance as described in section 1.2. For this reason, some scientific evidence of toxicity under repeated administration of tetrahydrofuran (stabilizer additive of benzylmagnesium chloride) were assessed.
No definitive scientific evidence of the onset of repeated dose related damage on target organ from tetrahydrofuran administration by inhalation route on mice and rats has arisen as described by related end-points records. For this reason and for the fact that no direct data for benzylmagnesium chloride with THF as stabilizer additive (as described in sect. 1.2) are available, it's not possible to classify this substance under CLP and DSD for this specific end-point.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.